Among patients with plaque psoriasis who received Enbrel, significant responses relative to placebo were apparent at the time of the first visit (2 weeks) and were maintained through 24 weeks of therapy. ###>23 Parmi les patients atteints de psoriasis en plaques qui recevaient Enbrel, des réponses significatives comparativement au placebo sont apparues à la première visite (2 semaines) et ont été maintenues durant les 24 semaines de traitement.